Cargando…
Immunogenicity of Bivalent Human Papillomavirus DNA Vaccine Using Human Endogenous Retrovirus Envelope-Coated Baculoviral Vectors in Mice and Pigs
Human papillomavirus is known to be the major pathogen of cervical cancer. Here, we report the efficacy of a bivalent human papillomavirus type 16 and 18 DNA vaccine system following repeated dosing in mice and pigs using a recombinant baculovirus bearing human endogenous retrovirus envelope protein...
Autores principales: | Lee, Hee-Jung, Hur, Yoon-Ki, Cho, Youn-Dong, Kim, Mi-Gyeong, Lee, Hoon-Taek, Oh, Yu-Kyoung, Kim, Young Bong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507738/ https://www.ncbi.nlm.nih.gov/pubmed/23209698 http://dx.doi.org/10.1371/journal.pone.0050296 |
Ejemplares similares
-
Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2
por: Cho, Hansam, et al.
Publicado: (2021) -
Immunogenicity of the Envelope Surface Unit of Human Endogenous Retrovirus K18 in Mice
por: Ilse, Victoria, et al.
Publicado: (2022) -
The envelope of human endogenous retrovirus in neuro-inflammation
por: Dougier, Hei-Lanne, et al.
Publicado: (2009) -
Syncytin, envelope protein of human endogenous retrovirus (HERV): no longer ‘fossil’ in human genome
por: Durnaoglu, Serpen, et al.
Publicado: (2022) -
Implication of Human Endogenous Retrovirus Envelope Proteins in Placental Functions
por: Lokossou, Adjimon Gatien, et al.
Publicado: (2014)